Uses the Revenir™ Product Engine to model and analyze the full spectrum of protein conformations derived from a single amino acid sequence, leveraging biophysics, machine learning, and computational chemistry. This approach enables the discovery of therapeutics that correct misfolded proteins and address diseases like genetic obesity and Parkinson’s, significantly improving the speed and accuracy of drug development compared to traditional methods.
Funding
$61.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
BVFounders
Product
Problem
Traditional drug discovery methods often treat proteins as static structures, overlooking the importance of their dynamic conformational changes in disease pathology. This limitation hinders the development of effective therapeutics for diseases caused by misfolded or dysfunctional proteins.
Solution
Congruence Therapeutics utilizes the Revenir™ Product Engine, a computational platform that models and analyzes the full spectrum of protein conformations derived from a single amino acid sequence. By integrating biophysics, machine learning, and computational chemistry, the platform enables the discovery of therapeutics that correct misfolded proteins and address diseases like genetic obesity and Parkinson’s disease. This approach facilitates the design of drugs that target specific protein conformations, improving the speed and accuracy of drug development compared to traditional methods. The Revenir™ engine generates and captures the biophysical properties of the full ensemble of protein conformers, allowing the company to move beyond static drug discovery processes towards predictive models.
Target Audience
The primary target audience includes pharmaceutical companies and research institutions focused on developing therapeutics for diseases caused by protein misfolding or dysfunction, such as genetic obesity and Parkinson's disease.
Features
- Revenir™ Product Engine: A proprietary platform for modeling protein dynamics and conformational changes.
- Biophysics-based simulations: Captures the full spectrum of protein shapes and their biophysical properties.
- Machine learning algorithms: Predicts protein conformations and identifies potential drug targets.
- Computational chemistry tools: Designs and optimizes therapeutic molecules that interact with specific protein conformations.
- In silico drug discovery: Enables the correction of disease pathogenesis through predictive modeling.